Literature DB >> 15447746

DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.

Ming Fang1, Edward Lew, Michael Klein, Thomas Sebo, Yingyao Su, Raj Goyal.   

Abstract

OBJECTIVES: To examine DNA content abnormalities in patients with Barrett's esophagus (BE) who progress to esophageal adenocarcinoma, using image cytometric DNA analysis (ICDA) of formalin-fixed tissues.
METHODS: Studies were performed on archived biopsies of BE patients' undergoing endoscopic surveillance before developing adenocarcinoma. A comparison group consisted of BE patients' free of cancer during a follow-up period of over 9 yr. Tissue sections were analyzed for the degree of dysplasia and for DNA content abnormalities, using image cytometry. Additional patients were also analyzed in a cross-sectional study of 56 BE cases with and without dysplasia, including 12 cases of adenocarcinoma.
RESULTS: Five patients developed adenocarcinoma during follow-up and earlier biopsies obtained before cancer diagnosis showed specialized intestinal metaplasia (SIM) followed by low-grade dysplasia (LGD) in one, SIM followed by high-grade dysplasia (HGD) in one, LGD in two, and HGD in one case. All five showed some DNA abnormality at baseline or in interval biopsies. In the comparison group, five of seven patients showed normal diploid DNA at baseline and on follow-up biopsies. One patient initially had diploid DNA, but developed aneuploidy 11 yr later. Another case initially had aneuploidy, but was diploid on follow-up. Overall, DNA abnormalities were found in 13% of cases with SIM without dysplasia, 60% with LGD, 73% with HGD, and 100% with adenocarcinoma.
CONCLUSIONS: (i) Image cytometric DNA analysis is a useful method to examine DNA abnormalities in formalin-fixed tissues and may be more sensitive in predicting progression to adenocarcinoma than HGD. (ii) Histological dysplasia of any grade and DNA abnormalities, help identify BE patients at high risk for adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447746     DOI: 10.1111/j.1572-0241.2004.30886.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy.

Authors:  Thomas D Wang; George Triadafilopoulos; James M Crawford; Lisa R Dixon; Tarun Bhandari; Peyman Sahbaie; Shai Friedland; Roy Soetikno; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-27       Impact factor: 11.205

Review 2.  Open questions in oesophageal adenocarcinogenesis.

Authors:  Carlo C Maley
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

3.  Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium.

Authors:  Weitian Liu; Hejin Hahn; Robert D Odze; Raj K Goyal
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

4.  Three-dimensional DNA image cytometry by optical projection tomographic microscopy for early cancer diagnosis.

Authors:  Nitin Agarwal; Alberto M Biancardi; Florence W Patten; Anthony P Reeves; Eric J Seibel
Journal:  J Med Imaging (Bellingham)       Date:  2014-06-20

5.  Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus.

Authors:  Nicole Vogt; René Schönegg; Jürgen M Gschossmann; Jan Borovicka
Journal:  Surg Endosc       Date:  2009-12-08       Impact factor: 4.584

6.  Predicting Neoplastic Progression in Barrett's Esophagus.

Authors:  Jean S Wang; Marcia I Canto
Journal:  Ann Gastroentol Hepatol       Date:  2010-06

7.  A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.

Authors:  Emily G Barr Fritcher; Shannon M Brankley; Benjamin R Kipp; Jesse S Voss; Michael B Campion; Larry E Morrison; Mona S Legator; Lori S Lutzke; Kenneth K Wang; Thomas J Sebo; Kevin C Halling
Journal:  Hum Pathol       Date:  2008-07-07       Impact factor: 3.466

8.  Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  Jian-Chun Cai; Di Liu; Kai-Hua Liu; Hai-Ping Zhang; Shan Zhong; Ning-Sao Xia
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 9.  Predictors of progression in Barrett's esophagus: current knowledge and future directions.

Authors:  Ganapathy A Prasad; Ajay Bansal; Prateek Sharma; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2010-01-26       Impact factor: 10.864

Review 10.  Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

Authors:  Chin-Ann J Ong; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.